Fluoroestradiol

CHEMBL1627367 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
290.4 g/mol
LogP
3.5
Phase
4

Used in PET imaging to evaluate estrogen receptor status in breast cancer and endometriosis lesions. This radiotracer helps doctors visualize hormone-sensitive tissue without invasive biopsy, guiding treatment decisions for hormone-dependent conditions.

Moleküler Ağırlık

290,4000 g/mol

LogP

3,50

TPSA

40,50 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](F)[C@@H]2O

InChI

InChI=1S/C18H23FO2/c1-18-7-6-13-12-5-3-11(20)8-10(12)2-4-14(13)15(18)9-16(19)17(18)21/h3,5,8,13-17,20-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1

Molecular Formula

C18H23FO2

HBD / HBA

2 / 3

Döndürülebilir Bağlar

0

Ağır Atomlar

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Used in PET imaging to evaluate estrogen receptor status in breast cancer and endometriosis lesions. This radiotracer helps doctors visualize hormone-sensitive tissue without invasive biopsy, guiding treatment decisions for hormone-dependent conditions.

Yes, Fluoroestradiol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1627367. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 10401972. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.